Lasker, J M <br/><br/>
Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.  [electronic resource] 

 -  Archives of biochemistry and biophysics  May 1998 
 - 16-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0003-9861 
<br/><br/><label>Standard No.: </label>10.1006/abbi.1998.0615  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--metabolism<br/>Aryl Hydrocarbon Hydroxylases<br/>Chromatography, DEAE-Cellulose<br/>Chromatography, Ion Exchange<br/>Cytochrome P-450 CYP2C19<br/>Cytochrome P-450 CYP2C8<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 Enzyme System--isolation & purification<br/>Electrophoresis, Polyacrylamide Gel<br/>Humans<br/>Hydroxylation<br/>Kinetics<br/>Mephenytoin--pharmacokinetics<br/>Microsomes, Liver--enzymology<br/>Mixed Function Oxygenases--isolation & purification<br/>Omeprazole--pharmacokinetics<br/>Steroid 16-alpha-Hydroxylase<br/>Steroid Hydroxylases--isolation & purification<br/>Substrate Specificity<br/>Tolbutamide--pharmacokinetics<br/>Ultrafiltration